SCHEDULE 13G

CUSIP No.

171757206

1

Names of Reporting Persons

Canaan XII L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No.

171757206

1

Names of Reporting Persons

Canaan Partners XII LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

CIDARA THERAPEUTICS, INC.

(b)

Address of issuer's principal executive offices:

6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121

Item 2.

(a)

Name of person filing:

(i) Canaan XII L.P., a Cayman Islands limited partnership; and (ii) Canaan Partners XII LLC, a Delaware limited liability company.

(b)

Address or principal business office or, if none, residence:

2765 Sand Hill Road, Menlo Park, California 94025

(c)

Citizenship:

See Item 2(a) above.

(d)

Title of class of securities:

COMMON STOCK, $0.0001 PAR VALUE PER SHARE

(e)

CUSIP No.:

171757206

Item 4.

Ownership

(a)

Amount beneficially owned:

As of June 30, 2025, none of the Reporting Persons may be deemed to beneficially own any shares of Common Stock of the Issuer.

(b)

Percent of class:

0.0 %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

0

(ii) Shared power to vote or to direct the vote:

0

(iii) Sole power to dispose or to direct the disposition of:

0

(iv) Shared power to dispose or to direct the disposition of:

0

Item 5.

Ownership of 5 Percent or Less of a Class.

Ownership of 5 percent or less of a class

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Canaan XII L.P.

Signature:	/s/ Nancy Levenson
Name/Title:	Nancy Levenson, Attorney-in-Fact
Date:	08/14/2025

Canaan Partners XII LLC

Signature:	/s/ Nancy Levenson
Name/Title:	Nancy Levenson, Attorney-in-Fact
Date:	08/14/2025